On the evening of the 2nd Beijing time, U.S. stocks rose more than 6% in early trading on Thursday after the company reported that it benefited from cutstekken3arcadeIn response to cost actions, the company's quarterly loss narrowed than expected in its most recent quarter.

The company reported a loss per share of 3tekken3arcade$.07, revenue of 1tekken3arcade.67 billion US dollars. Analysts surveyed by LSEG expected the company to lose $3.58 per share and revenue of $97.5 million.

Moderna also reiteratedtekken3arcadeIts full-year guidance for 2024 is approximately US$4 billion, which includes potential revenue from its RSV vaccine.